Beau Ventures
$1.1B 13F equity value
23 Holdings
Quarter ended September 30, 2026
The latest 13F on file for Beau Ventures covers the quarter ended September 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| GOOG | ALPHABET INC | 1,400,131 | $477M | 45.0% |
| MRNA | MODERNA INC | 1,000,056 | $193M | 18.2% |
| META | META PLATFORMS INC | 200,051 | $145M | 13.7% |
| ILMN | ILLUMINA INC | 200,078 | $55M | 5.2% |
| IBM | INTERNATIONAL BUSINESS MACHS | 158,528 | $35M | 3.3% |
| CVS | CVS HEALTH CORP | 325,432 | $28M | 2.6% |
| ADBE | ADOBE INC | 100,080 | $24M | 2.3% |
| BIIB | BIOGEN INC | 100,000 | $23M | 2.1% |
| EBA | EBAY INC. | 200,000 | $21M | 2.0% |
| DYH | TARGET CORP | 100,000 | $16M | 1.5% |
Track Beau Ventures's 13F portfolio: $1.1B in reported holdings, 23 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}